Scrub Typhus Meningitis: Signs, Symptoms, and Treatment
For suspected scrub typhus meningitis, initiate doxycycline immediately while awaiting confirmatory testing, as this treatable infection can rapidly progress to multiorgan dysfunction and death if left untreated.
Clinical Presentation
Key Signs and Symptoms
Scrub typhus meningitis presents with a constellation of features that overlap significantly with other forms of meningitis, making clinical diagnosis challenging:
Classic Features:
- Fever (present in nearly all cases) with shorter duration compared to tuberculous meningitis 1
- Headache (common presenting symptom)
- Altered mental status (ranging from mild confusion to coma) 2, 3
- Eschar (pathognomonic when present, but found in only 28% of neurological cases) 2
- Rash (may be present but not universal)
Neurological Manifestations:
- Meningoencephalitis (most common CNS presentation) 2, 4
- Seizures, including status epilepticus 5, 4
- Cranial nerve palsies (VII, VIII, IX, X) 6
- Acute flaccid paralysis 2
- Cortical multifocal myoclonus 4
- Parkinsonism (rare) 2
Systemic Features:
- Thrombocytopenia (57% of cases) 2
- Elevated liver transaminases (SGOT >40 IU/L, SGPT >60 IU/L) 1
- Hyponatremia (42% of cases) 2
- Acute kidney injury 3
- Multiorgan dysfunction syndrome 3
Critical Diagnostic Pitfall
The absence of classic meningeal signs does NOT rule out scrub typhus meningitis. Patients often present with less severe neurological impairment compared to tuberculous meningitis, and the eschar—while pathognomonic—is frequently absent 2, 1. The illness typically has a shorter pre-admission fever duration than other causes of lymphocytic meningitis 1.
Diagnostic Approach
Laboratory Findings That Favor Scrub Typhus Over Other Lymphocytic Meningitis
CSF Analysis:
- Lower CSF WBC count (mean 130.8 cells/mm³ vs 195 in TBM; often <100 cells/mm³) 1
- Lower CSF protein (mean 125 mg/dL vs 195 in TBM; often <100 mg/dL) 1
- Higher CSF glucose (mean 70.1 mg/dL vs 48.7 in TBM; often >50 mg/dL) 1
- Lymphocytic pleocytosis (57% of cases) 2
Serum Markers:
- Markedly elevated ferritin (AUC 0.870 for diagnosis) 7
- Elevated procalcitonin (AUC 0.846 for diagnosis) 7
- Elevated CRP (AUC 0.814) 7
- Total leukocyte count >10,000/mm³ 1
Confirmatory Testing:
- IgM ELISA for Orientia tsutsugamushi in serum and CSF 6
- Next-generation sequencing (NGS) of CSF for rapid pathogen identification 8, 5
- Multipathogen metagenomic testing when conventional antibiotics fail 5
Imaging Findings
MRI may reveal:
- Meningeal enhancement (temporal lobe, tentorium cerebelli) 5
- Basal ganglia involvement 4
- Extra-limbic cortical changes 4
- Findings mimicking autoimmune or arboviral encephalitis 4
Treatment Guidelines
Antibiotic Therapy
First-Line Treatment:
- Doxycycline (intravenous or oral depending on severity)
Alternative/Adjunctive Therapy:
When to Suspect and Treat Empirically
Initiate doxycycline immediately if:
- Patient presents with fever, headache, and altered mental status in endemic areas
- CSF shows lymphocytic pleocytosis with protein <100 mg/dL and glucose >50 mg/dL
- Elevated ferritin or PCT levels are present
- No response to conventional antibacterial (ceftriaxone) and antiviral (acyclovir) therapy after 48-72 hours 5
- Presence of systemic features: thrombocytopenia, elevated transaminases, acute kidney injury
Critical Management Points
Do NOT wait for serological confirmation before starting doxycycline in clinically suspected cases, especially when:
- Patient is deteriorating
- Multiorgan dysfunction is developing
- Conventional therapy for bacterial/viral meningitis has failed 5
Adjunctive Therapy:
- Corticosteroids may be beneficial in severe cases with meningoencephalitis 6
- Supportive care for multiorgan dysfunction 3
- Seizure management as needed 4
Prognosis and Outcomes
With appropriate treatment:
- Complete clinical recovery is expected in the majority (89%) of cases 2
- All patients in reported series achieved full recovery with no recurrences or fatalities 1, 7
- Good functional outcomes (mRS) in most cases 2
Without treatment or with delayed diagnosis:
- Rapid progression to multiorgan dysfunction syndrome 3
- Increased mortality risk
- Potential for permanent neurological sequelae
Key Clinical Algorithm
Suspect scrub typhus meningitis in any patient with:
- Fever + headache + altered mental status in endemic areas
- Lymphocytic CSF with relatively preserved glucose and modest protein elevation
- Elevated ferritin/PCT
- Failure to respond to standard meningitis therapy
Examine thoroughly for eschar (axilla, groin, scalp, genitalia)
Order immediately:
- Scrub typhus IgM ELISA (serum and CSF)
- CSF NGS/metagenomic testing if available
- Ferritin, PCT, liver enzymes, complete blood count
Start doxycycline empirically while awaiting results
Expect clinical improvement within 48 hours—if no improvement, reconsider diagnosis
Avoid prolonged empirical antituberculous therapy in cases where scrub typhus is likely 1